In Vivo Treatment of Hemophilia A and Mucopolysaccharidosis Type VII Using Nonprimate Lentiviral Vectors
Open Access
- 30 June 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 3 (6) , 850-856
- https://doi.org/10.1006/mthe.2001.0325
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Efficient lentiviral transduction of liver requires cell cycling in vivoNature Genetics, 2000
- Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defectJournal of Clinical Investigation, 1999
- Advances toward Gene Therapy for Hemophilia at the MillenniumHuman Gene Therapy, 1999
- Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectorsNature Medicine, 1998
- Sustained expression of genes delivered directly into liver and muscle by lentiviral vectorsNature Genetics, 1997
- Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cellsBlood, 1993
- Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblastsNature Genetics, 1993
- Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIIIBlood, 1993
- Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transferNature, 1992
- Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantationBlood, 1991